117 related articles for article (PubMed ID: 14524486)
21. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
23. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
Verburg FA; Mäder U; Luster M; Reiners C
Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
[TBL] [Abstract][Full Text] [Related]
24. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
25. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
[TBL] [Abstract][Full Text] [Related]
26. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.
Lin HW; Bhattacharyya N
Laryngoscope; 2010 Apr; 120(4):712-6. PubMed ID: 20205241
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
28. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
[TBL] [Abstract][Full Text] [Related]
30. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
32. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
33. Locally advanced differentiated thyroid carcinoma: a 35-year mono-institutional experience in 280 patients.
Rosa Pelizzo M; Toniato A; Boschin IM; Piotto A; Bernante P; Pagetta C; Palazzi M; Maria Guolo A; Preo P; Nibale O; Rubello D
Nucl Med Commun; 2005 Nov; 26(11):965-8. PubMed ID: 16208173
[TBL] [Abstract][Full Text] [Related]
34. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
35. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP
Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009
[TBL] [Abstract][Full Text] [Related]
36. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
37. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
38. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
39. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
40. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy.
Chow SM; Law SC; Mendenhall WM; Au SK; Chan PT; Leung TW; Tong CC; Wong IS; Lau WH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):784-95. PubMed ID: 11849802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
